In a report released today, Alexander Nowak from Craig-Hallum maintained a Buy rating on Sensus Healthcare (SRTS – Research Report). The company’s shares closed last Friday at $2.90.
Nowak covers the Healthcare sector, focusing on stocks such as Tandem Diabetes Care, REPRO-MED Systems, and Exact Sciences. According to TipRanks, Nowak has an average return of 3.4% and a 45.00% success rate on recommended stocks.
Sensus Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $8.50.
See today’s best-performing stocks on TipRanks >>
Based on Sensus Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.41 million and a GAAP net loss of $1.89 million. In comparison, last year the company earned a revenue of $10.34 million and had a net profit of $16.06 million
Based on the recent corporate insider activity of 12 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SRTS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sensus Healthcare, Inc. engages in the design, manufacture, and marketing of proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions. Its main product is SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Read More on SRTS:
- Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
- Sensus Healthcare Completes Installation of its First SRT System in Ireland
- Sensus Healthcare completes installation of first SRT system in Ireland
- Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
- Sensus Healthcare management to meet virtually with Roth MKM
